Novartis

Vasella’s $78 Million Novartis Payout Boosts ‘Fat-Cat’ Crackdown

Vasella’s $78 Million Novartis Payout Boosts ‘Fat-Cat’ Crackdown

Bloomberg

Pfizer to Novartis Seen Gaining as Drought Ends: Health

Pfizer to Novartis Seen Gaining as Drought Ends: Health

Bloomberg

Novartis Marrow Drug Fails to Win U.K. Agency Backing

Novartis Marrow Drug Fails to Win U.K. Agency Backing

Bloomberg

Will The Flu Vaccine Race Send Novartis Higher?

Will The Flu Vaccine Race Send Novartis Higher?

Seeking Alpha

Big Pharma's Uphill 2013 Battle

Big Pharma's Uphill 2013 Battle

Motley Fool

How Big Pharma Gets Bigger, And What Little Pharma Can Do About It

How Big Pharma Gets Bigger, And What Little Pharma Can Do About It

Seeking Alpha

Incyte Pharmaceuticals Is Primed For A Run

Incyte Pharmaceuticals Is Primed For A Run

Seeking Alpha

Novartis Recalls OTC Cough Syrups

Novartis Recalls OTC Cough Syrups

Motley Fool

EU Charges J&J And Novartis With Pay-To-Delay

EU Charges J&J And Novartis With Pay-To-Delay

Pharmalot

Opko Health: A Potential $8.3 Billion A Year Company In The Making

Opko Health: A Potential $8.3 Billion A Year Company In The Making

Seeking Alpha